Vimta Labs Limited — Others, 28-04-2025: Change in Director(s)

Vimta Labs has announced a board meeting to recommend the reappointment of Dr. Yadagiri R. Pendri as an independent director for a second and final term of five years, from August 10, 2025, to August 9, 2030, subject to shareholder approval at the forthcoming Annual General Meeting. Dr. Pendri, with over 35 years of experience in pharmaceutical research and development, has a proven track record in leading innovation and managing strategic partnerships, contributing to advancements in drug development.

This reappointment may provide continuity in governance and strategic direction, potentially enhancing confidence among investors regarding the company's future innovations and partnerships in the biotech sector. Investor sentiment could lean positively, given Dr. Pendri’s extensive expertise and industry connections, which may further strengthen Vimta's market positioning.